Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 1341-1360 of 3,347 trials

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

NCT03583086

This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation and dose expansion study of combinatorial oral vorolanib plus infusional nivolumab in patients with Non-Small Cell Lung Cancer naïve to checkpoint inhibitor therapy, Non-Small Cell Lung Cancer who have progressed on checkpoint inhibitor therapy, Small Cell Lung Cancer ( who have progressed on platinum-based chemotherapy, and thymic carcinoma.

Thymic CarcinomaNon-small Cell Lung CancerRefractory Thoracic Tumors+1 more

Vanderbilt-Ingram Cancer Center88 participantsStarted Jul 2018

Palo Alto, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

NCT03124160

This will be a multi-site, participant-blinded, randomized clinical trial. The investigators will randomize 1000 eligible participants in a 4:1 ratio to two different copper IUDs: 800 to Mona Lisa NT Cu380 Mini and 200 to ParaGard.

Healthy WomenFemale Contraception

FHI 3601,105 participantsStarted May 2017

Los Angeles, California, United States • Sacramento, California, United States • San Francisco, California, United States +13 more locations

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

Rheumatoid Arthritis Trials in Other Cities

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

AI ENRICH - AI Detection of ICH

Adhesive Tape Trauma Evaluation of Two Gentle Tapes

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults

Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH

Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

Virtual Reality Glove for Hand and Arm Rehabilitation After Stroke

Other Conditions in Philadelphia